TScan Therapeutics (TCRX) Interest & Investment Income (2020 - 2026)
TScan Therapeutics' (TCRX) quarterly Interest & Investment Income came in at $1.2 million in Q1 2026, up 2212.73% year-on-year from $50243.7 in Q1 2025, and up 115.95% on a QoQ basis from -$7.3 million in Q4 2025.
TScan Therapeutics (TCRX) Interest & Investment Income (2020 - 2026) Analysis & Trends
TScan Therapeutics (TCRX) has 7 years of Interest & Investment Income data on file, last reported at $1.2 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 2212.73% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was -$1.7 million, a 22.93% increase from a year earlier, with the FY2025 full-year figure at -$51000.0, down 200.0% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $1.2 million, up from -$7.3 million in the prior quarter.
- Over the last five years, Interest & Investment Income for TCRX reached as high as $3.7 million in Q3 2024 and fell as low as -$9.2 million in Q4 2024.
- Historically, Interest & Investment Income has averaged $464411.8 across 5 years, with a median of $1.2 million in 2026.
- Across the five-year window, Interest & Investment Income soared 44950.0% in 2022 and sank 455.82% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $901000.0 in 2022, then surged by 188.12% to $2.6 million in 2023, then sank by 455.82% to -$9.2 million in 2024, then increased by 21.14% to -$7.3 million in 2025, then surged by 115.95% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $1.2 million in Q1 2026, -$7.3 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | TScan Therapeutics | 100.59 Mn | -27.47 Mn | - | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | -7.28 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.39 Mn |
| Mar 31, 2025 | -55,000.00 |
| Dec 31, 2024 | -9.24 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.14 Mn |
| Dec 31, 2022 | 901,000.00 |
| Sep 30, 2022 | 534,000.00 |
| Jun 30, 2022 | 149,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 5,000.00 |